The 2023 GOLD Guidelines

COPD is a common and complex disease for both inpatient and outpatient providers. GOLD guidelines provide diagnosis and treatment recommendations for COPD and were recently updated. Join host Geoff Wall as he breaks down the salient recommendations in the 2023 GOLD guidelines. The GameChangerA new severity scoring system for COPD exists – category E. Additionally, inhaled corticosteroids may play a larger role in the pharmacotherapy of COPD.Show Segments00:00 - Introductions01:40 - Background on COPD04:09 - The GameChanger: Severity Scoring Changes08:23 - Connecting to Practice: Impact of Inhaler Technique16:08 - Use of Inhaled Corticosteroids23:23 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and Resources2023 GOLD ReportRedeem your CPE or CME hereCPE (Pharmacist) CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new severity scoring system for COPD in the 2023 GOLD guidelines2. Discuss appropriate use of inhaled corticosteroids in COPD patients0.05 CEU/0.5 HrUAN: 0107-0000-22-422-H04-PInitial release date: 12/20/2022Expiration date: 12/20/2023Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram